{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-086865","form_type":"8-K","ticker":"TLSI","cik":"0001826667","company_name":"TriSalus Life Sciences, Inc.","filed_at":"2023-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.517990+00:00","generated_at":"2026-06-12T14:43:38.429207+00:00","sec_items":["5.07","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"MedTech Acquisition adjourns special meeting on TriSalus merger to Aug 8; redemption deadline extended to Aug 4","bullets":["Special meeting for TriSalus business combination adjourned to August 8, 2023 at 11:00 a.m. ET.","Vote to adjourn: 7,134,393 for, 1,777 against; quorum of 96.5% voting power present.","Redemption deadline for public stockholders extended to August 4, 2023 at 5:00 p.m. ET.","Prior to meeting, MTAC filed 8-K regarding FDA written response for TriSalus' PERIO-01 clinical program."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-086865","json":"https://secwatch.observer/filing/0001104659-23-086865.json","markdown":"https://secwatch.observer/filing/0001104659-23-086865.md","text":"https://secwatch.observer/filing/0001104659-23-086865.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1826667/000110465923086865/0001104659-23-086865-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1826667/000110465923086865/tm2322702d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T14:43:38.429207+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}